Home

Kokulu Silgi sessiz ol ara cell fachinformation Somatik hücre restoran devam etmekte

ARA-cell 1000 mg/4000 mg Infusionslösung
ARA-cell 1000 mg/4000 mg Infusionslösung

A proof of concept phase I/II pilot trial of LSD1 inhibition by  tranylcypromine combined with ATRA in refractory/relapsed AML patients not  eligible for intensive therapy. - Abstract - Europe PMC
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC

Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche  und Synopse der Evidenz zur Bestimmung der zweckmä
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä

Identification of solubility-limited absorption of oral anticancer drugs  using PBPK modeling based on rat PK and its relevance to human -  ScienceDirect
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect

Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with  Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties |  Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

A proof of concept phase I/II pilot trial of LSD1 inhibition by  tranylcypromine combined with ATRA in refractory/relapsed AML patients not  eligible for intensive therapy. - Abstract - Europe PMC
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with  Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties |  Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

QuapoS 4 - ESOP | European Society of Oncology Pharmacy
QuapoS 4 - ESOP | European Society of Oncology Pharmacy

US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents
US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents

ARA-cell 100 mg/ml Konzentrat
ARA-cell 100 mg/ml Konzentrat

MATRIX / High-dose chemotherapy and autologous stem cell transplant or  consolidating conventional chemotherapy in primary CNS ly
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents
US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with  Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties |  Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

MATRIX / High-dose chemotherapy and autologous stem cell transplant or  consolidating conventional chemotherapy in primary CNS ly
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly

Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche  und Synopse der Evidenz zur Bestimmung der zweckmä
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä

Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

A Clinical Drugâ•'Drug Interaction Study Assessing a Novel Drug Transporter  Phenotyping Cocktail With Adefovir, Sitagliptin
A Clinical Drugâ•'Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin

STADAPHARM
STADAPHARM

Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink

Regulatory T cells and myeloid-derived suppressor cells in metastatic renal  cell carcinoma: Modulation by sorafenib and sunitini
Regulatory T cells and myeloid-derived suppressor cells in metastatic renal cell carcinoma: Modulation by sorafenib and sunitini

STADApharm
STADApharm